Purpose:The aim of this study was to investigate the effects of the diagnosis, treatment,. Methods: A retrospective single-center analysis of all patients who underwent diagnostic and surgical procedures due to GCT was performed from September 2018 to September 2021. Results: 65 patients were enrolled into the study by dividing them into two groups as before pandemic (Pre-CovGCT) and during the pandemic (CovGCT). 33 patients in the Pre-CovGCT group and 32 patients in the CovGCT group were evaluated and compared. A significant increase was observed for symptom duration (p = 0.018), the duration between diagnosis and surgical procedure (p = 0.028), and occult metastasis risk of stage 1 tumors (p = 0.05) during the pandemic period. Conclusions: The duration of symptoms and the duration between the diagnosis and surgical procedure were prolonged in GCT patients diagnosed during the pandemic. Furthermore, an increased risk of occult metastasis has been observed in stage 1 GCT patients. We underline the importance of raising the awareness of patients about admission to the hospital without delay in the presence of testicular cancer symptoms and recommend to be careful not to delay the treatment process.
Amaç: Kadın cinsel disfonksiyonu toplumumuzda yüksek prevalansla izlenmesine karşın etiyolojisi ve tedavi yaklaşımları nadir olarak incelenmiştir. Bu çalışmada kadın cinsel işlev ölçeğine etki eden muhtemel faktörler araştırılarak bu sık görülen patolojiyle ilgili öngörü sağlanması amaçlanmıştır. Gereç ve Yöntem: Sağlık Bilimleri Üniversitesi Ankara Sağlık Araştırma ve Uygulama Merkezi Üroloji ve Kadın Hastalıkları ve Doğum polikliniklerine farklı sebeplerle başvuru yapan, aktif cinsel yaşamı ve partneri olan toplam 50 kadın gönüllülük esası ile çalışmaya alındı. Gerekli bilginin verilmesini takiben, Türkçe'ye valide edilmiş kadın cinsel fonksiyon sorgulama formunun hemşire eşliğinde tamamlanması sağlandı. Bulgular: Hastaların ortalama yaşı 41.4±12.51 olarak saptandı ve tüm grup yaş, komorbidite varlığı, menapoz durumu, eğitim düzeyi ve ailenin sosyoekonomik durumuna göre alt gruplara ayrıştırıldı. Kadın Cinsel Fonksiyon İndeks skoru ileri yaştaki, postmenapozal ve komorbiditeye sahip hastalarda anlamlı olarak düşük saptanırken eğitim durumu ve sosyoekonomik durum ile ilişki saptanmamıştır. Sonuç: İleri yaş, menapoza girmiş olma ve diyabet, hipertansiyon ve kardiyak patoloji gibi ek komorbiditeye sahip olunması kadınlar için cinsel disfonksiyon yaratan durumlardır. Objective: Despite the high prevalance of female sexual dysfuntion in our population, its etiology and treatment strategies are rarely studied. The factors which probably affect the Female Sexual Function Index (FSFI) score are investigated in order to give insight to this frequently seen pathology. Material and Methods: The study was carried out on 50 sexually active female patients with existing partners who admitted to University of Health Sciences Ankara Health Research and Training Center Obstetrics and Gynecology and Urology Outpatient Clinics. The validated Turkish FSFI form was completed under the supervision of a nurse based on the principle of volunteerism. Results: Training and Research Hospital Obstetrics and Gynecology and Urology Outpatient Clinics. Results: The mean age of the patients was 41.4±12.51 years. The patients were grouped according to age, existing comorbidity, being in the menopausal period, educational level and economical status. The FSFI scores were significantly lower in higher age, existing comorbidity and menopausal group. No differences were detected between the different levels of education and economic status. Conclusion: Being elderly, being in menopausal status and having pathologies such as hypertension, diabetes, and cardiac diseases have a negative effect on female sexuality. Anahtar Kelimeler: Kadın cinsel disfonksiyonu, risk faktörleri, kadın cinsel fonksiyon indeksi Keywords: Female sexual dysfunction, risk factors, female sexual function index Keseroğlu BB ve ark. Kadın Cinsel İşlev Ölçeği KÜ Tıp Fak Derg 2018;22(3):269-273
Purpose The aim of this study was to determine the correlation between the dwelling time for a ureteral stent placed for passive dilation after impassable ureteroscopy and success and complications. Methods A retrospective evaluation was made of patients who underwent stent placement after impassable ureteroscopy and a repeat ureteroscopy due to kidney stones. A total of 161 patients were included in the study between 2015–2022. Demographic, clinical, preoperative, and perioperative data were collected. Logistic regression analyses were performed on the data showing a significant difference in the univariate analyses performed to determine the predictive factors of ureteroscopy after the stent dwelling period in terms of stone-free status and perioperative complications. Results Stone-free status was achieved in 110 (68.3%) of 161 patients, and perioperative complications were observed in 41 (25.4%). Factors that affected the stone-free status were determined as the dwelling time and the S-ReSC score, while factors affecting perioperative complications were the stent dwelling time and the operation time. The stone-free rates were observed to increase from 46.4% in the first 2 weeks to 72.9% after the 2nd week, an increase of 1.5-fold. Perioperative complications were determined at the rate of 17.5% during the first 5 weeks and increased 2.1-fold to 37.5% after the 5th week. Conclusion It can be recommended that great care is taken during the stent dwelling period and ureteroscopy should be performed within 5 weeks (14–35 days) but no earlier than 2 weeks, so as not to affect the success of the procedure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.